HIV-1 infection in a man homozygous for CCR5 Delta 32

被引：220
|
作者：
OBrien, TR
Winkler, C
Dean, M
Nelson, JAE
Carrington, M
Michael, NL
White, GC
机构：
[1] NCI,LAB GENOM DIVERS,US PHS,US DEPT HHS,BETHESDA,MD 20852
[2] WALTER REED ARMY INST RES,DEPT RETROVIROL,ROCKVILLE,MD
[3] UNIV N CAROLINA,DIV HEMATOL & ONCOL,CAPEL HILL SCH MED,CHAPEL HILL,NC
[4] UNIV N CAROLINA,DIV HEMATOL & ONCOL,SCH MED,CHAPEL HILL,NC
[5] UNIV N CAROLINA,LINEBERGER COMPREHENS CANC CTR,SCH MED,CHAPEL HILL,NC
来源：
LANCET | 1997年 / 349卷 / 9060期
关键词：
D O I：
10.1016/S0140-6736(97)24017-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1219 / 1219
页数：1
相关论文
共 50 条
  • [31] HIV-1 infection through the CCR5 receptor is blocked by receptor dimerization
    Vila-Coro, AJ
    Mellado, M
    de Ana, AM
    Lucas, P
    del Real, G
    Martinez, C
    Rodriguez-Frade, JM
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (07) : 3388 - 3393
  • [32] Host genes and HIV: The role of the chemokine receptor gene CCR5 and its allele (Delta 32 CCR5)
    McNicholl, JM
    Smith, DK
    Qari, SH
    Hodge, T
    [J]. EMERGING INFECTIOUS DISEASES, 1997, 3 (03) : 261 - 271
  • [33] Inhibition of HIV-1 infection by synthetic peptides derived CCR5 fragments
    Imai, Masaki
    Baranyi, Lajos
    Okada, Noriko
    Okada, Hidechika
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2007, 353 (04) : 851 - 856
  • [34] Relationship between productive HIV-1 infection of macrophages and CCR5 utilization
    Hung, CS
    Pontow, S
    Ratner, L
    [J]. VIROLOGY, 1999, 264 (02) : 278 - 288
  • [35] Prognostic Value of a CCR5 Defective Allele in Pediatric HIV-1 Infection
    Maria Luisa Romiti
    Claudia Colognesi
    Caterina Cancrini
    Antonio Mas
    Monica Berrino
    Francesca Salvatori
    Paola Orlandi
    Marianne Jansson
    Elvia Palomba
    Anna Plebani
    Jose M. Bertran
    Manuel Hernandez
    Maurizio de Martino
    Antonio Amoroso
    Pier Angelo Tovo
    Paolo Rossi
    Teresa Espanol
    Gabriella Scarlatti
    [J]. Molecular Medicine, 2000, 6 : 28 - 36
  • [36] CCR5 antagonists and HIV-1 infection: Bases and consequences of this therapeutic approach
    Psomas, K. C.
    Corbeau, P.
    Reynes, J.
    [J]. ANTIBIOTIQUES, 2010, 12 (01): : 27 - 41
  • [37] CCR5 genotype and HIV-1 infection in perinatally-exposed infants
    Mas, A
    Español, T
    Heredia, A
    Pedraza, MA
    Hernandez, M
    Caragol, I
    Fernando, M
    Bertran, JM
    Alcami, J
    Soriano, V
    [J]. JOURNAL OF INFECTION, 1999, 38 (01) : 9 - 11
  • [38] Polymorphism in the CCR5 gene promoter and HIV-1 infection in North Indians
    Kaur, Gurvinder
    Singh, P.
    Rapthap, C. C.
    Kumar, N.
    Vajpayee, M.
    Sharma, S. K.
    Wanchu, A.
    Mehra, N. K.
    [J]. HUMAN IMMUNOLOGY, 2007, 68 (05) : 454 - 461
  • [39] The CCR5 receptor acts as an alloantigen in CCR5Δ32 homozygous individuals:: Identification of chemokine- and HIV-1-blocking human antibodies
    Ditzel, HJ
    Rosenkilde, MM
    Garred, P
    Wang, M
    Koefoed, K
    Pedersen, C
    Burton, DR
    Schwartz, TW
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (09) : 5241 - 5245
  • [40] CCR5Δ32 mutation and HIV infection: basis for curative HIV therapy
    Allers, Kristina
    Schneider, Thomas
    [J]. CURRENT OPINION IN VIROLOGY, 2015, 14 : 24 - 29
12345